Roche, the global pharmaceutical company from Switzerland, today announced it will scoop up Flatiron Health, a startup analyzing real-time oncology data to help cancer patients and doctors, in a $1.9 billion deal. Flatiron has also confirmed the deal to TechCrunch.
Read More
Powered by WPeMatico
